We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
- Authors
Van Cutsem, Eric; Moiseyenko, Vladimir M; Tjulandin, Sergei; Majlis, Alejandro; Constenla, Manuel; Boni, Corrado; Rodrigues, Adriano; Fodor, Miguel; Chao, Yee; Voznyi, Edouard; Risse, Marie-Laure; Ajani, Jaffer A; V325 Study Group
- Abstract
In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin and fluorouracil (CF; reference regimen) in the phase III part.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 31, p4991
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.06.8429